In contrast, neuromuscular disease-causing mutations occur on the outer surface of the TRPV4 tetramer, suggesting that the pathogenic consequences of these mutations may result from altered interactions with ARD binding partners (10, 12, 22, 27, 28). This evidence concerns the gene TRPV4 and neuromuscular disease.